Deep And Global Bioethics For A Livable Third Millennium

In three short years it will be Jan. 1, 2001, the first day of the 21st century and a new era. The United States will be expecting the inaugural message of a new president and the world will enter the Third Millennium. As the Second Millennium ends, we ought to think about what kind of a world we should and could realistically hope for. We certainly need a world with fewer than the often-predicted 12 billion people who may be present before the end of the 21st century. Unfortunately, in our mad

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

In three short years it will be Jan. 1, 2001, the first day of the 21st century and a new era. The United States will be expecting the inaugural message of a new president and the world will enter the Third Millennium. As the Second Millennium ends, we ought to think about what kind of a world we should and could realistically hope for. We certainly need a world with fewer than the often-predicted 12 billion people who may be present before the end of the 21st century. Unfortunately, in our mad scramble to maintain the capitalistic civilization that attempts to accelerate excess consumption throughout the world, we give little thought to who sits at the table and who goes hungry. On the "Bridge to the 21st Century" we may preempt our chances of arriving at the 25th century or the year 3000. Will we exit from the third millennium ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Van Rensselaer Potter

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide